Abstract
Background:Denosumab, a monoclonal antibody of receptor activator of NF-κB ligand promotes a strong action for bone mineral density (BMD) gain. This agent is often used for patient with rheumatoid arthritis...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
